Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Ansemant, Thiphaine ^a   Mahy, Sophie ^a   Piroth, Christine ^a   Ornetti, Paul ^a,c   Ewing, Stephanie ^a   Guilland, Jean Claude ^a   Croisier, Delphine ^a   Duvillard, Laurence ^a   Chavanet, Pascal ^a,b   Maillefert, Jean Francis ^a,b,c   Piroth, Lionel ^a,b  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c INSERM   (France)

Author keywords

25 hydroxyvitamin D; Antiretroviral therapy; Bone metabolism; HIV; Inflammation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBOXY TERMINAL TELOPEPTIDE; INTEGRASE INHIBITOR; INTERLEUKIN 6; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PARATHYROID HORMONE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR;

ADDICTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL EXAMINATION; CONSULTATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE SEVERITY; FEEDING BEHAVIOR; FEMALE; FUNCTIONAL STATUS; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTPATIENT; SMOKING; SUN EXPOSURE; VITAMIN D DEFICIENCY;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; BONE AND BONES; FEMALE; HIV INFECTIONS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; RISK FACTORS; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84871896265     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-7     Document Type: Article

References (23)

1. Rodriguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-Positive patients. AIDS Res Hum Retroviruses 2009, 25:9-14. 10.1089/aid.2008.0183, 19108690.
2. Blanchard P. Masterclass: HIV-infection and osteopathy. Int J Osteop Med 2009, 12:115-120.
3. Vescini F, Cozzi-Lepri A, Borderi M, Re MC, Maggiolo F, De Luca A, et al. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J Acquir Immune Defic Syndr 2011, 58:163-172. 10.1097/QAI.0b013e31822e57e9, 21826011.
4. Viard JP, Souberbielle JC, Kirk O, Reekie J, Knysz B, Losso M, et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011, 25:1305-1315. 10.1097/QAD.0b013e328347f6f7, 21522006.
5. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012, 367:40-49. 10.1056/NEJMoa1109617, 22762317.
6. Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010, 65:225-236. 10.1016/j.maturitas.2009.12.013, 20031348.
7. Overton ET, Yin MT. The rapidly evolving research on vitamin D among HIV-infected populations. Curr Infect Dis Rep 2011, 13:83-93. 10.1007/s11908-010-0144-x, 21308459.
8. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, Sweep FC, Hermus AR, Bosch ME, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008, 24:1375-1382. 10.1089/aid.2008.0058, 18928396.
9. Libois A, Clumeck N, Kabeya K, Gerard M, De Wit S, Poll B, et al. Risk factors of osteopenia in HIV-infected women: no role of antiretroviral therapy. Maturitas 2010, 65:51-54. 10.1016/j.maturitas.2009.10.009, 19939594.
10. Piso RJ, Rothen M, Rothen JP, Stahl M. Markers of bone turnover are elevated in patients with antiretroviral treatment independent of the substance used. J Acquir Immune Defic Syndr 2011, 56:320-324. 10.1097/QAI.0b013e31820cf010, 21350365.
11. McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Tebas P, et al. Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: aids clinical trials group A5224s, a substudy of ACTG A5202. J Infect Dis 2011, 203:1791-1801. 10.1093/infdis/jir188, 3100514, 21606537.
12. Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med 2006, 166:64-70. 10.1001/archinte.166.1.64, 16401812.
13. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008, 5:e203. 10.1371/journal.pmed.0050203, 2570418, 18942885.
14. Fardellone P, Sebert JL, Bouraya M, Bonidan O, Leclercq G, Doutrellot C, et al. [Evaluation of the calcium content of diet by frequential self-questionnaire]. Rev Rhum Mal Osteoartic 1991, 58:99-103.
15. Mueller NJ, Fux CA, Ledergerber B, Elzi L, Schmid P, Dang T, et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010, 24:1127-1134. 10.1097/QAD.0b013e328337b161, 20168200.
16. Calmy A, Gayet-Ageron A, Montecucco F, Nguyen A, Mach F, Burger F, et al. HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial. AIDS 2009, 23:929-939. 10.1097/QAD.0b013e32832995fa, 19425222.
17. Dao CN, Patel P, Overton ET, Rhame F, Pals SL, Johnson C, et al. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011, 52:396-405. 10.1093/cid/ciq158, 21217186.
18. Bucharles S, Barberato SH, Stinghen AE, Gruber B, Meister H, Mehl A, et al. Hypovitaminosis D is associated with systemic inflammation and concentric myocardial geometric pattern in hemodialysis patients with low iPTH levels. Nephron Clin Pract 2011, 118:c384-c391. 10.1159/000323664, 21325871.
19. Bellia A, Garcovich C, D'Adamo M, Lombardo M, Tesauro M, Donadel G, et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 2011, Epub ahead of print.
20. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine 2010, 77:552-557. 10.1016/j.jbspin.2010.09.018, 21067953.
21. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004, 291:1999-2006. 10.1001/jama.291.16.1999, 15113819.
22. George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, et al. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol 2009, 15:3516-3522. 10.3748/wjg.15.3516, 2715978, 19630107.
23. Wasserman P, Rubin DS. Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient Care STDS 2010, 24:223-227. 10.1089/apc.2009.0241, 20377437.